EyeCyte Company
EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases.
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
PharmTech
Investors Number:
1
Number Of Exists:
N/A
Technology:
Small Molecules
Founded Date:
2005
Investor Type:
N/A
Headquarters:
La Jolla, California, United States
Total Funding:
$3M
Last Funding Type:
Series A
Employee Number:
1-10
Investment Stage:
N/A